Opsonophagocytic assay as a potentially useful tool for assessing safety of enterococcal preparations

被引:19
作者
Hufnagel, M [1 ]
Koch, S [1 ]
Kropec, A [1 ]
Huebner, J [1 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA
关键词
Enterococcus; opsonophagocytosis; safety; probiotics;
D O I
10.1016/S0168-1605(03)00189-2
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Enterococci are commonly used in foods and food additives. A number of putative virulence factors are usually evaluated to assure that the strains used are not harmful. We propose an additional test to assess the safety of these bacteria by testing the susceptibility to opsonophagocytic killing. One probiotic Enterococcus faecalis strain was compared to a collection of 27 clinical isolates and our results indicate that 89% of the clinical strains were less susceptible to killing mediated by normal rabbit sera. Opsonophagocytic killing is the best in vitro surrogate for a protective immune response against bacteria, and the susceptibility of bacteria against normal rabbit sera indicates that these strains may not be able to survive in the bloodstream of the host. Further studies comparing a larger collection of pathogenic strains with commensal isolates are necessary to confirm these findings. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 19 条
[1]  
Aarestrup FM, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P55
[2]   ROLES OF ANTIBODIES AND COMPLEMENT IN PHAGOCYTIC KILLING OF ENTEROCOCCI [J].
ARDUINO, RC ;
MURRAY, BE ;
RAKITA, RM .
INFECTION AND IMMUNITY, 1994, 62 (03) :987-993
[3]   PLASMID-ASSOCIATED HEMOLYSIN AND AGGREGATION SUBSTANCE PRODUCTION CONTRIBUTE TO VIRULENCE IN EXPERIMENTAL ENTEROCOCCAL ENDOCARDITIS [J].
CHOW, JW ;
THAL, LA ;
PERRI, MB ;
VAZQUEZ, JA ;
DONABEDIAN, SM ;
CLEWELL, DB ;
ZERVOS, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2474-2477
[4]   Incidence of virulence factors and antibiotic resistance among enterococci isolated from food [J].
Franz, CMAP ;
Muscholl-Silberhorn, AB ;
Yousif, NMK ;
Vancanneyt, M ;
Swings, J ;
Holzapfel, WH .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (09) :4385-4389
[5]   Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium [J].
Huebner, J ;
Wang, Y ;
Krueger, WA ;
Madoff, LC ;
Martirosian, G ;
Boisot, S ;
Goldmann, DA ;
Kasper, DL ;
Tzianabos, AO ;
Pier, GB .
INFECTION AND IMMUNITY, 1999, 67 (03) :1213-1219
[6]   Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci [J].
Huebner, J ;
Quaas, A ;
Krueger, WA ;
Goldmann, DA ;
Pier, GB .
INFECTION AND IMMUNITY, 2000, 68 (08) :4631-4636
[7]   VIRULENCE OF ENTEROCOCCI [J].
JETT, BD ;
HUYCKE, MM ;
GILMORE, MS .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (04) :462-&
[8]   PROPOSAL OF A NEW SCHEME FOR THE SEROLOGICAL TYPING OF ENTEROCOCCUS-FAECALIS STRAINS [J].
MAEKAWA, S ;
YOSHIOKA, M ;
KUMAMOTO, Y .
MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (07) :671-681
[9]   Relationships between enterococcal virulence and antimicrobial resistance [J].
Mundy, LM ;
Sahm, DF ;
Gilmore, M .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) :513-+
[10]   Drug therapy: Vancomycin-resistant enterococcal infections. [J].
Murray, BE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (10) :710-721